- Home
- ATLO vs CGEN Comparison
ATLO vs CGEN Comparison
Compare ATLO & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- CGEN
- Stock Information
- Founded
- ATLO 1903
- CGEN 1993
- Country
- ATLO United States
- CGEN Israel
- Employees
- ATLO N/A
- CGEN N/A
- Industry
- ATLO Major Banks
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATLO Finance
- CGEN Health Care
- Exchange
- ATLO Nasdaq
- CGEN Nasdaq
- Market Cap
- ATLO 158.4M
- CGEN 149.6M
- IPO Year
- ATLO N/A
- CGEN 2000
- Fundamental
- Price
- ATLO $17.61
- CGEN $1.41
- Analyst Decision
- ATLO
- CGEN Strong Buy
- Analyst Count
- ATLO 0
- CGEN 1
- Target Price
- ATLO N/A
- CGEN $4.00
- AVG Volume (30 Days)
- ATLO 12.6K
- CGEN 264.2K
- Earning Date
- ATLO 05-07-2025
- CGEN 05-19-2025
- Dividend Yield
- ATLO 4.57%
- CGEN N/A
- EPS Growth
- ATLO N/A
- CGEN N/A
- EPS
- ATLO 1.14
- CGEN N/A
- Revenue
- ATLO $53,455,000.00
- CGEN $27,864,000.00
- Revenue This Year
- ATLO N/A
- CGEN $11.81
- Revenue Next Year
- ATLO N/A
- CGEN $28.37
- P/E Ratio
- ATLO $15.42
- CGEN N/A
- Revenue Growth
- ATLO 2.24
- CGEN N/A
- 52 Week Low
- ATLO $15.69
- CGEN $1.35
- 52 Week High
- ATLO $22.03
- CGEN $2.66
- Technical
- Relative Strength Index (RSI)
- ATLO 41.65
- CGEN 29.77
- Support Level
- ATLO $17.27
- CGEN $1.50
- Resistance Level
- ATLO $17.91
- CGEN $1.65
- Average True Range (ATR)
- ATLO 0.32
- CGEN 0.06
- MACD
- ATLO -0.04
- CGEN -0.00
- Stochastic Oscillator
- ATLO 40.36
- CGEN 3.45
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.